Definition of COPD

COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual patients.

Its pulmonary component is characterized by airflow limitation that is not fully reversible.

The airflow limitation is usually progressive and associated with an abnormal inflammatory response of the lung to noxious particles or gases.

Inflammation in COPDInflammation in COPDINFLAMMATION IN COPD

Small airway diseaseAirway inflammationAirway remodeling

Parenchymal destructionLoss of alveolar attachments

Decrease of elastic recoil

AIRFLOW LIMITATION

Noxious particles

and gases

Lung inflammation

Host factors

COPD pathology

ProteinasesOxidative stress

Anti -proteinasesAnti -oxidants

Repair mechanisms

Pathogenesis of COPDPathogenesis of COPD

Diagnosis of COPD

SYMPTOMS

coughsputumdyspnea

EXPOSURE TO RISKFACTORS

tobaccooccupation

indoor/outdoor pollution

SPIROMETRY

Spirometry: Normal and Patients with COPD

Spirometry GuideSpirometry Quick GuideSpirometry Teaching Slide Set

To help health care professionals understand how to perform & evaluate spirometry.

All resources available at www.goldcopd.org.

Spirometry “How-To” Resources from GOLD

Classification of COPD Severity by Spirometry

Stage I: Mild FEV1/FVC < 0.70 FEV1 > 80% predicted

Stage II: Moderate FEV1/FVC < 0.70 50% < FEV1 < 80% predicted

Stage III: Severe FEV1/FVC < 0.70 30% < FEV1 < 50% predicted

Stage IV: Very Severe FEV1/FVC < 0.70 FEV1 < 30% predicted or

FEV1 < 50% predicted plus chronic respiratory failure

IV: Very Severe III: Severe II: Moderate I: Mild

Therapy at Each Stage of COPDTherapy at Each Stage of COPD

• FEV1/FVC < 70%

• FEV1 > 80% predicted

• FEV1/FVC < 70%

• 50% < FEV1 < 80% predicted

• FEV1/FVC < 70%

• 30% < FEV1 < 50% predicted

• FEV1/FVC < 70%

• FEV1 < 30% predictedor FEV1 < 50%

predicted plus chronic respiratory failure

Add regular treatment with one or more long-acting bronchodilators (when needed); Add rehabilitation

Add inhaled glucocorticosteroids if repeated exacerbations

Active reduction of risk factor(s); influenza vaccinationAdd short-acting bronchodilator (when needed)

Add long term oxygen if chronic respiratory failure. Consider surgical treatments

Differential Diagnosis: Differential Diagnosis: COPD and AsthmaCOPD and Asthma

COPD ASTHMA

• Onset in mid-life

• Symptoms slowly progressive

• Long smoking history

• Dyspnea during exercise

• Largely irreversible airflow

limitation

• Onset early in life (often childhood)

• Symptoms vary from day to day

• Symptoms at night/early morning

• Allergy, rhinitis, and/or eczema also

present

• Family history of asthma

• Largely reversible airflow limitation

COPD and Co-morbid ConditionsCOPD and Co-morbid Conditions

Common co-morbid conditions in COPD patients: Cardiovascular disease Lung cancer Osteoporosis Musculoskeletal disorders Depression/anxiety Obesity/type II diabetes

Physicians should identify and treat co-morbid conditions that impact on the clinical course of COPD.

Smoking prevention and cessation, weight control, exercise, and rehabilitation have the potential to beneficially affect COPD and co-morbid conditions.

Preventing COPD ExacerbationsPreventing COPD Exacerbations

Prevent respiratory infections: pneumococcal vaccine, annual influenza vaccine.

Avoid air pollution: remain indoors and close windows on bad air pollution days.

Quit smoking and avoid exposure to secondhand smoke.

Understand medication regimen and proper inhaler use.

Patients with severe COPD and repeated exacerbations (3 or more in a year): use inhaled glucocorticosteroids.

Recognize and respond to early signs of exacerbations to minimize impact when exacerbations do occur.

Risk Factors for COPD

Oxidative stress

Gender

Age

Respiratory infections

Socioeconomic status

Nutrition

Comorbidities

Genes

Exposure to particles

●Tobacco smoke

●Occupational dusts, organic and inorganic

●Indoor air pollution from heating and cooking with biomass in poorly ventilated dwellings

●Outdoor air pollution

Lung growth and development

Brief Strategies to Help the Patient Willing to Quit Smoking

• ASK Systematically identify all tobacco users at every visit.

• ADVISE Strongly urge all tobacco users to quit.

• ASSESS Determine willingness to make a quit attempt.

• ASSIST Aid the patient in quitting.

• ARRANGE Schedule follow-up contact.

Anatomy of the Anatomy of the Lower Respiratory SystemLower Respiratory System

Trachea

LeftRight

Main bronchi

Bronchus

Bronchioles

Acinus

Alveolus

Acinus

Alveolus

Capillaries

rigid because ofC-shapedcartilage rings

Capillary

Alveolarspace

Attenuatedepithelium

Anatomy of the AirwaysAnatomy of the Airways

Trachea and major bronchi Bronchioles

MucusCiliaSecretory cells

Ciliated cells

Basal membrane

Submucosa

Smooth muscle

Connective tissue

Cartilage

Mucous membrane

Epithelium

Airway mucous membrane